| Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor H Yu, C Yang, L Jian, S Guo, R Chen, K Li, F Qu, K Tao, Y Fu, F Luo, S Liu Oncology reports 42 (2), 826-838, 2019 | 185 | 2019 |
| CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis C Yang, H Yu, R Chen, K Tao, L Jian, M Peng, X Li, M Liu, S Liu International journal of oncology 55 (3), 684-696, 2019 | 66 | 2019 |
| Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients Y Peng, R Chen, F Qu, Y Ye, Y Fu, Z Tang, Y Wang, B Zong, H Yu, F Luo, ... Cancer Biology & Therapy 21 (2), 189-196, 2020 | 37 | 2020 |
| Novel breast-specific long non-coding RNA LINC00993 acts as a tumor suppressor in triple-negative breast cancer S Guo, L Jian, K Tao, C Chen, H Yu, S Liu Frontiers in oncology 9, 1325, 2019 | 32 | 2019 |
| Angiogenesis-related gene expression signatures predicting prognosis in gastric cancer patients H Ren, J Zhu, H Yu, AV Bazhin, CB Westphalen, BW Renz, SN Jacob, ... Cancers 12 (12), 3685, 2020 | 27 | 2020 |
| A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma H Yu, Y Fu, Z Tang, L Jiang, C Qu, H Li, Z Tan, D Shu, Y Peng, S Liu Aging (Albany NY) 14 (2), 989, 2022 | 14 | 2022 |
| Lysophosphatidic acid receptor 6 (LPAR6) expression and prospective signaling pathway analysis in breast cancer K Tao, S Guo, R Chen, C Yang, L Jian, H Yu, S Liu Molecular Diagnosis & Therapy 23, 127-138, 2019 | 14 | 2019 |
| Construction and validation of an immune infiltration-related gene signature for the prediction of prognosis and therapeutic response in breast cancer Y Peng, H Yu, Y Jin, F Qu, H Ren, Z Tang, Y Zhang, C Qu, B Zong, S Liu Frontiers in Immunology 12, 666137, 2021 | 13 | 2021 |
| Assessment of the predictive role of serum lipid profiles in breast cancer patients receiving neoadjuvant chemotherapy F Qu, R Chen, Y Peng, Y Ye, Z Tang, Y Wang, B Zong, H Yu, S Liu Journal of Breast Cancer 23 (3), 246, 2020 | 12 | 2020 |
| A novel immune-related gene signature predicting survival in sarcoma patients H Ren, AV Bazhin, E Pretzsch, S Jacob, H Yu, J Zhu, M Albertsmeier, ... Molecular Therapy-Oncolytics 24, 114-126, 2022 | 8 | 2022 |
| Identification of target genes related to sulfasalazine in triple-negative breast cancer through network pharmacology H Yu, K Hu, T Zhang, H Ren Medical Science Monitor: International Medical Journal of Experimental and …, 2020 | 6 | 2020 |
| Development of a prognostic model based on pyroptosis-related genes in pancreatic adenocarcinoma K Su, Y Peng, H Yu Disease Markers 2022, 2022 | 5 | 2022 |
| A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma Y Peng, H Yu, Y Zhang, F Qu, Z Tang, C Qu, J Tian, B Zong, Y Wang, ... Scientific Reports 11 (1), 17610, 2021 | 5 | 2021 |
| AGR3 promotes estrogen receptor‑positive breast cancer cell proliferation in an estrogen‑dependent manner L Jian, J Xie, S Guo, H Yu, R Chen, K Tao, C Yang, K Li, S Liu Oncology Letters 20 (2), 1441-1451, 2020 | 5 | 2020 |
| Sulfasalazine induces ferroptosis of breast cancer ZR-75-1 cells and its mechanism H YU Tumor, 933-941, 2018 | 4 | 2018 |
| Optimization of rhodamine 123 adsorbed onto graphene oxide for tracing therapeutics processes J Liao, L Li, H Yu, A Deng, Z Yuan Spectroscopy Letters 52 (2), 105-112, 2019 | 1 | 2019 |
